Loading publications…
The last 5 uploaded publications
Therapy-Related Myeloid Neoplasms After [<sup>177</sup>Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series
Michal Eifer, Duncan E. K. Sutherland, Isaac Goncalves, James Buteau, Lewis Au, Arun Azad, Louise Emmett, Grace Kong, Louise Kostos, Aravind S. Ravi Kumar, Edmond M. Kwan, Elizabeth Medhurst, Shahneen Sandhu, Ben Tran, Alexander W. Wyatt, Michael S. Hofman (2025). Therapy-Related Myeloid Neoplasms After [<sup>177</sup>Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series. , DOI: https://doi.org/10.2967/jnumed.124.268640.
Article62 days agoSafety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review
Duncan E. K. Sutherland, Raghava Kashyap, Price Jackson, James Buteau, Declan G. Murphy, B.D. Kelly, Lavinia Spain, Shahneen Sandhu, Arun Azad, Elizabeth Medhurst, Grace Kong, Michael S. Hofman (2023). Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review. , 15, DOI: https://doi.org/10.1177/17588359231177018.
Article62 days ago